Goldman Sachs maintains Biocon at 'buy' with a price target of INR275.00

  • Investing.com
Goldman Sachs maintains Biocon at 'buy' with a price target of INR275.00

An analyst from Goldman Sachs maintained Biocon (NS: BION ) at 'buy' with a price target of INR275.00 from a prior price target of %currency%%price%.

Prior to this rating, Biocon had 14 buy ratings, 4 hold ratings, and 3 sell ratings.

For consensus analyst estimates and price targets on Biocon, click here. For more news on Biocon, click here.

Biocon's stock price closed at $242.90. They are up 5.2% in the last month and down -25.08% in the last 12 months.

According to Investing Pro, Biocon's fair value is $302.04, an upside of 22.81%. Biocon's fair value comes with a medium degree of uncertainty, according to InvestingPro.

Check out Biocon's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles